Acromegaly Completed Phase Trials for Lanreotide (DB06791)
Also known as: Acromegalic / Acromegaly (disorder)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0000951 (Acromegaly) | Completed | Not Available |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT01840449 | Somatuline Predictive Factors in Acromegaly and NET | ||
| NCT00703079 | Impact of Somatostatin Analogs vs. Surgery on Glucose Metabolism in Acromegaly | ||
| NCT00652379 | Co-treatment With Pegvisomant and a Somatostatin Analogue (SA) in SA-responsive Acromegalic Patients | Treatment |